Strs Ohio Liquidia Corp Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$11.96 - $15.71 $70,564 - $92,689	5,900 Added 65.56%	14,900 $178,000
Q1 2024 May 13, 2024	SELL	$11.35 - $16.73 $6,810 - $10,038	-600 Reduced 6.25%	9,000 $132,000
Q4 2023 Jan 30, 2024	SELL	$5.77 - $12.19 $406,207 - $858,176	-70,400 Reduced 88.0%	9,600 $115,000
Q3 2023 Oct 26, 2023	BUY	$6.27 - $8.15 $501,599 - $652,000	80,000 New	80,000 $507,000
Q3 2022 Oct 27, 2022	BUY	$3.73 - $8.39 $43,268 - $97,324	11,600 New	11,600 $63,000
Q1 2019 Apr 19, 2019	SELL	$10.82 - $21.79 $15,148 - $30,506	-1,400 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$10.96 - $28.9 $15,344 - $40,460	1,400 New	1,400 $38,000

171

44.3M

1.55M

1.52M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $633M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.